ADALTA LIMITED - Corporate Spotlight

0.00%

0.4¢

Market Cap $11.90M

Healthcare Biotechnology

AdAlta Limited is an Australia-based drug discovery and development company. The Company... AdAlta Limited is an Australia-based drug discovery and development company. The Company is focused on using its technology platform to generate protein therapeutics, known as i-bodies, for treating a range of human diseases. The Company's principal activity is to develop its ibody platform with a focus on its lead candidate AD-114, a treatment for idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases. Its i-body AD-114 drug candidate is used for treatment in various fibrosis related eye diseases to support the pre-clinical development of the eye fibrosis indication. The Company's AD-114 has shown both anti-fibrotic and anti-inflammatory effects in various animal models. The Company's AD-114 is used in various therapeutic applications for fibrosis diseases of the liver, skin, kidney and heart. AD-114 has completed pre-clinical studies in vitro (in the lab) and in vivo (in animals) data obtained.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No Corporate Spotlight currently available.

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $11.90M

Open	High	Low	Volume
0.4¢	0.4¢	0.4¢	401.9K

Buyers (Bids)

Vol.	Price($)
26763664	0.3¢

Sellers (Offers)

Price($)	Vol.
0.4¢	11209721

Last trade - 10.23am 29/07/2026 (20 minute delay)

1AD (ASX) Chart